Caribou Biosciences, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
CRBU on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2929 7 Th Street, Suite 105, Berkeley, CA

Insiders trading volume in the past year

Caribou Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other* $9.84M Jul 27, 2021
Rachel E. Haurwitz President and CEO, Director $3.74M +$20.4K +0.55% Mar 14, 2025
Barbara G. Mcclung Chief Legal Officer $951K -$4.81K -0.5% Feb 20, 2025
Steven Kanner Chief Scientific Officer $641K -$4.81K -0.75% Feb 20, 2025
Syed Ali-aamir Rizvi Chief Medical Officer $528K Feb 21, 2023
Jason O'Byrne Chief Financial Officer $512K Feb 20, 2024
Ruhi Ahmad Khan Chief Business Officer $443K -$4.81K -1.07% Feb 20, 2025
Ryan Fischesser VP of Finance and Controller $320K Nov 20, 2024
David Lee Johnson Director $106K Feb 20, 2025
Scott Braunstein Director $106K Feb 20, 2025
Dara Richardson-Heron Director $106K Feb 20, 2025
Natalie Sacks Director $106K Feb 20, 2025
Andrew Guggenhime Director $106K Feb 20, 2025
Ran Zheng Director $57.8K Feb 20, 2025
Nancy Whiting Director $57.8K Feb 20, 2025
Timothy P. Kelly Chief Technology Officer $50.6K Feb 20, 2025
Sriram Ryali Chief Financial Officer $24.7K +$24.7K Jan 29, 2025
Tina M. Albertson Chief Medical Officer $19.7K Feb 20, 2025
Jeffrey Long-McGie Director Jul 22, 2021

Recent Insider Transactions by Companies or Individuals for Caribou Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.